General Grant

Financial contribution to support a program or project that does not fit any of the other defined grant categories.

  • Areas of Interest

    Biogen considers requests across a variety of disease areas including: 
    Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Lupus, Multiple Sclerosis, Ophthalmology, Parkinson’s Disease and Spinal Muscular Atrophy.

  • How to Apply

    All requests for US or Global grants will be accepted and reviewed on a quarterly basis. Funding requests should be submitted during the open submission period in the quarter prior to when a funding decision is needed. Biogen reserves the right to decline any applications not adhering to the published submission cycle.  

    See below for quarterly submission periods and decision notification dates:

    Submission Cycle
    Open Date
    Submission Cycle
    Deadline Date
    Ineligible Review
    Notification Date
    Notification Date
    January 15 February 15 February 28 March 30
    April 15 May 15 May 29 June 30
    July 15 August 15 August 31 September 30
    October 1 November 1 November 16 January 5

    Requests outside of the US are accepted on a rolling basis. Please contact your local Biogen office to apply. 

  • Funding Requirements

    Grant requests must be unsolicited, should typically have multiple funders, and must not provide nor promise to Biogen any tangible benefit. Funding amounts requested must be reasonable for the activities proposed and grant funds must be used for the expenses described in the grant application and the grant approval agreement.

    Additionally, all prior requests from the organization approved by Biogen must be appropriately reconciled before any new applications from the organization will be considered for funding.

    Biogen will conduct appropriate due diligence on all applicants and requests, and reserves the right to deny any application that does not meet the requirements.

  • Segregation from Commercial Initiatives

    Organizations must have sufficient separation (firewalls) between the grant requestor’s or partner’s promotional and medical education business units. Grants from organizations engaged by marketing or promotional functions within Biogen will be scrutinized to ensure appropriate separation exists between the part of the organization providing marketing or promotional services to Biogen and the part of the organization seeking a grant.

  • Funding Restrictions & Limitations

    Requests for funding must be submitted by an eligible organization.

    Funding must not be used for:

    • Travel, lodging or registration expenses for non-faculty healthcare professionals to attend an educational program
    • Operating expenses that are not directly and exclusively dedicated to the educational activity being applied for (e.g. equipment, salaries, benefits, journal subscriptions, etc.)
    • Support a promotional exhibit or display space/fees (please submit requests for exhibit fees under the Sponsorships request category)
    • Stand-alone entertainment or social events
    • Staff/professional development
    • Advertising space
    • Programs that take place in a location, venue or in a schedule that detracts from the educational activity as the primary purpose

    To avoid the appearance of lack of independence of our applicants, Biogen will review the organization’s annual operating expenses against the level of individual and aggregate funding provided to an organization on a rolling twelve (12) month basis.

  • Review Process and Decision

    All grant requests will be reviewed on a quarterly basis. Funding requests should be submitted in the quarter prior to when a funding decision is needed by the organization.

    Funding decisions for Grants are made through a formal, centralized grant review and decision-making process. Grant Review Committees assess and approve applications based upon need, design, scientific rigor, independence and compliance, as well as the potential to improve patient care and outcomes. Approvals depend on available funding, the volume of requests, and alignment with Biogen’s Areas of Interest. The Grant Review Committee may request additional detail or clarification of the activity’s description or proposed budget, or other items, prior to the final funding decision.

    In all cases, Biogen notifies applicants of our decision by email. Notification of decision shall only be communicated by the Grants Management & Strategic Giving Office and no other Biogen staff member is authorized to approve or decline requests.  We receive many qualified and deserving applications and regret that we cannot fund all of them. All applications receive a fair review, and we encourage organizations to reapply for future programs and initiatives.

  • Contracting

    All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA), which is issued electronically to an authorized signatory of the organization once the application is approved. The organization must agree to the terms of the LOA before the program start date. Payment will be issued upon execution of the LOA.

  • Program Execution

    If the scope of an approved activity changes, organizations must submit such changes to in advance of the start date. Biogen will review the scope changes and assess whether funding for the activity should continue.

    Organizations will have the opportunity to provide a project status update and program outcomes throughout the course of the program's implementation. 

  • Reconciliation

    Within 90 days of the event or program end date, recipient organizations must complete a reconciliation confirming receipt of funds and attesting that they were used for the purposes described in the LOA. The reconciliation will be assessed against the approved use of funding.

    An organization’s failure to appropiately submit a reconciliation by the due date may delay or prohibit future funding of applications.